Annual Operating Profit
-$353.71 M
+$56.48 M+13.77%
31 December 2023
Summary:
Ionis Pharmaceuticals annual operaing income is currently -$353.71 million, with the most recent change of +$56.48 million (+13.77%) on 31 December 2023. During the last 3 years, it has fallen by -$203.75 million (-135.87%). IONS annual operating profit is now -196.67% below its all-time high of $365.88 million, reached on 31 December 2019.IONS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$148.62 M
-$82.53 M-124.87%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly operating income is currently -$148.62 million, with the most recent change of -$82.53 million (-124.87%) on 30 September 2024. Over the past year, it has dropped by -$5.30 million (-3.70%). IONS quarterly operating profit is now -157.02% below its all-time high of $260.65 million, reached on 31 December 2019.IONS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$370.33 M
-$5.30 M-1.45%
30 September 2024
Summary:
Ionis Pharmaceuticals TTM operating income is currently -$370.33 million, with the most recent change of -$5.30 million (-1.45%) on 30 September 2024. Over the past year, it has increased by +$185.29 million (+33.35%). IONS TTM operating profit is now -201.22% below its all-time high of $365.88 million, reached on 31 December 2019.IONS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.8% | -3.7% | +33.4% |
| 3 y3 years | -135.9% | -75.1% | -57.7% |
| 5 y5 years | -476.3% | -5990.5% | -419.2% |
IONS Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2299.8% | +13.8% | -167.7% | +28.5% | -2222.1% | +33.4% |
| 5 y | 5 years | -196.7% | +13.8% | -157.0% | +28.5% | -201.2% | +33.4% |
| alltime | all time | -196.7% | +13.8% | -157.0% | +28.5% | -201.2% | +33.4% |
Ionis Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$148.62 M(+124.9%) | -$370.33 M(+1.5%) |
| June 2024 | - | -$66.09 M(-55.8%) | -$365.03 M(-6.2%) |
| Mar 2024 | - | -$149.51 M(+2346.2%) | -$389.13 M(+10.0%) |
| Dec 2023 | -$353.71 M(-13.8%) | -$6.11 M(-95.7%) | -$353.77 M(-36.3%) |
| Sept 2023 | - | -$143.31 M(+58.9%) | -$555.63 M(+17.9%) |
| June 2023 | - | -$90.19 M(-21.0%) | -$471.45 M(+1.0%) |
| Mar 2023 | - | -$114.15 M(-45.1%) | -$466.77 M(+13.8%) |
| Dec 2022 | -$410.20 M(+2683.1%) | -$207.97 M(+251.7%) | -$410.12 M(-2450.1%) |
| Sept 2022 | - | -$59.14 M(-30.8%) | $17.45 M(-311.1%) |
| June 2022 | - | -$85.51 M(+48.7%) | -$8.27 M(-152.9%) |
| Mar 2022 | - | -$57.50 M(-126.2%) | $15.63 M(-206.1%) |
| Dec 2021 | -$14.74 M(-90.2%) | $219.60 M(-358.8%) | -$14.74 M(-93.7%) |
| Sept 2021 | - | -$84.86 M(+37.7%) | -$234.84 M(+25.9%) |
| June 2021 | - | -$61.61 M(-29.9%) | -$186.47 M(+5.6%) |
| Mar 2021 | - | -$87.87 M(>+9900.0%) | -$176.62 M(+17.8%) |
| Dec 2020 | -$149.96 M(-141.0%) | -$499.00 K(-98.6%) | -$149.88 M(-234.7%) |
| Sept 2020 | - | -$36.49 M(-29.5%) | $111.28 M(-26.0%) |
| June 2020 | - | -$51.75 M(-15.3%) | $150.29 M(-18.0%) |
| Mar 2020 | - | -$61.13 M(-123.5%) | $183.22 M(-49.9%) |
| Dec 2019 | $365.88 M(-696.2%) | $260.65 M(>+9900.0%) | $365.88 M(+215.4%) |
| Sept 2019 | - | $2.52 M(-113.4%) | $116.02 M(+22.2%) |
| June 2019 | - | -$18.83 M(-115.5%) | $94.92 M(+49.6%) |
| Mar 2019 | - | $121.53 M(+1026.9%) | $63.47 M(-203.4%) |
| Dec 2018 | -$61.37 M(-297.7%) | $10.79 M(-158.1%) | -$61.37 M(-21.7%) |
| Sept 2018 | - | -$18.57 M(-63.1%) | -$78.35 M(+61.7%) |
| June 2018 | - | -$50.28 M(+1423.2%) | -$48.47 M(-686.7%) |
| Mar 2018 | - | -$3.30 M(-46.8%) | $8.26 M(-73.4%) |
| Dec 2017 | $31.05 M(-254.0%) | -$6.20 M(-154.8%) | $31.05 M(-70.3%) |
| Sept 2017 | - | $11.31 M(+75.4%) | $104.56 M(-4.4%) |
| June 2017 | - | $6.45 M(-66.9%) | $109.35 M(+102.6%) |
| Mar 2017 | - | $19.48 M(-71.1%) | $53.98 M(-367.7%) |
| Dec 2016 | -$20.16 M(-73.4%) | $67.31 M(+317.9%) | -$20.16 M(-86.6%) |
| Sept 2016 | - | $16.11 M(-132.9%) | -$150.41 M(-29.9%) |
| June 2016 | - | -$48.93 M(-10.5%) | -$214.66 M(+77.3%) |
| Mar 2016 | - | -$54.65 M(-13.2%) | -$121.08 M(+59.8%) |
| Dec 2015 | -$75.76 M(+58.7%) | -$62.94 M(+30.8%) | -$75.76 M(+2664.1%) |
| Sept 2015 | - | -$48.14 M(-207.8%) | -$2.74 M(-111.5%) |
| June 2015 | - | $44.65 M(-578.5%) | $23.90 M(-187.3%) |
| Mar 2015 | - | -$9.33 M(-192.6%) | -$27.39 M(-42.6%) |
| Dec 2014 | -$47.73 M(-7.6%) | $10.08 M(-146.9%) | -$47.73 M(-38.5%) |
| Sept 2014 | - | -$21.49 M(+223.2%) | -$77.67 M(-4.9%) |
| June 2014 | - | -$6.65 M(-77.6%) | -$81.68 M(-1.5%) |
| Mar 2014 | - | -$29.67 M(+49.4%) | -$82.96 M(+60.6%) |
| Dec 2013 | -$51.67 M(-25.0%) | -$19.86 M(-22.1%) | -$51.67 M(-10.8%) |
| Sept 2013 | - | -$25.50 M(+221.7%) | -$57.93 M(-4.2%) |
| June 2013 | - | -$7.93 M(-587.9%) | -$60.47 M(+23.8%) |
| Mar 2013 | - | $1.63 M(-106.2%) | -$48.84 M(-29.1%) |
| Dec 2012 | -$68.92 M(-3.1%) | -$26.12 M(-6.9%) | -$68.92 M(+12.2%) |
| Sept 2012 | - | -$28.05 M(-858.8%) | -$61.42 M(+10.3%) |
| June 2012 | - | $3.70 M(-120.0%) | -$55.69 M(-24.2%) |
| Mar 2012 | - | -$18.45 M(-0.9%) | -$73.45 M(+3.3%) |
| Dec 2011 | -$71.10 M(+47.0%) | -$18.62 M(-16.6%) | -$71.10 M(+4.0%) |
| Sept 2011 | - | -$22.32 M(+58.7%) | -$68.34 M(+24.3%) |
| June 2011 | - | -$14.06 M(-12.7%) | -$54.97 M(-7.7%) |
| Mar 2011 | - | -$16.11 M(+1.6%) | -$59.59 M(+23.2%) |
| Dec 2010 | -$48.36 M(+75.6%) | -$15.86 M(+77.2%) | -$48.36 M(+9.5%) |
| Sept 2010 | - | -$8.95 M(-52.1%) | -$44.17 M(-3.2%) |
| June 2010 | - | -$18.67 M(+282.6%) | -$45.62 M(+43.6%) |
| Mar 2010 | - | -$4.88 M(-58.2%) | -$31.78 M(+15.4%) |
| Dec 2009 | -$27.54 M(+110.9%) | -$11.67 M(+12.3%) | -$27.54 M(+15.0%) |
| Sept 2009 | - | -$10.40 M(+115.4%) | -$23.94 M(+79.1%) |
| June 2009 | - | -$4.83 M(+651.9%) | -$13.37 M(+79.2%) |
| Mar 2009 | - | -$642.00 K(-92.1%) | -$7.46 M(-42.9%) |
| Dec 2008 | -$13.06 M(-60.3%) | -$8.08 M(-4688.6%) | -$13.06 M(+76.5%) |
| Sept 2008 | - | $176.00 K(-83.7%) | -$7.40 M(-397.9%) |
| June 2008 | - | $1.08 M(-117.3%) | $2.48 M(-113.6%) |
| Mar 2008 | - | -$6.24 M(+158.5%) | -$18.26 M(-44.5%) |
| Dec 2007 | -$32.92 M | -$2.41 M(-124.0%) | -$32.92 M(-25.9%) |
| Sept 2007 | - | $10.06 M(-151.2%) | -$44.42 M(-39.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | -$19.66 M(-5.9%) | -$73.02 M(+3.3%) |
| Mar 2007 | - | -$20.90 M(+50.2%) | -$70.68 M(+7.5%) |
| Dec 2006 | -$65.75 M(+30.9%) | -$13.91 M(-25.0%) | -$65.75 M(+8.0%) |
| Sept 2006 | - | -$18.54 M(+7.1%) | -$60.87 M(+11.0%) |
| June 2006 | - | -$17.32 M(+8.4%) | -$54.82 M(+10.1%) |
| Mar 2006 | - | -$15.98 M(+76.9%) | -$49.78 M(-0.9%) |
| Dec 2005 | -$50.22 M(-41.2%) | -$9.03 M(-27.7%) | -$50.22 M(-17.1%) |
| Sept 2005 | - | -$12.49 M(+1.8%) | -$60.56 M(-14.0%) |
| June 2005 | - | -$12.27 M(-25.3%) | -$70.45 M(-11.4%) |
| Mar 2005 | - | -$16.42 M(-15.2%) | -$79.51 M(-6.9%) |
| Dec 2004 | -$85.43 M(+10.7%) | -$19.37 M(-13.4%) | -$85.43 M(-2.4%) |
| Sept 2004 | - | -$22.38 M(+4.9%) | -$87.53 M(+3.9%) |
| June 2004 | - | -$21.34 M(-4.5%) | -$84.22 M(+4.5%) |
| Mar 2004 | - | -$22.34 M(+4.0%) | -$80.60 M(+4.4%) |
| Dec 2003 | -$77.17 M(+56.1%) | -$21.48 M(+12.7%) | -$77.18 M(+17.7%) |
| Sept 2003 | - | -$19.07 M(+7.6%) | -$65.57 M(+2.4%) |
| June 2003 | - | -$17.72 M(-6.3%) | -$64.01 M(+9.2%) |
| Mar 2003 | - | -$18.91 M(+91.6%) | -$58.63 M(+18.6%) |
| Dec 2002 | -$49.44 M(+7.2%) | -$9.87 M(-43.6%) | -$49.44 M(+4.6%) |
| Sept 2002 | - | -$17.51 M(+41.9%) | -$47.26 M(+37.1%) |
| June 2002 | - | -$12.34 M(+27.0%) | -$34.46 M(-10.7%) |
| Mar 2002 | - | -$9.72 M(+26.3%) | -$38.59 M(-16.3%) |
| Dec 2001 | -$46.10 M(+59.0%) | -$7.70 M(+63.5%) | -$46.10 M(-4.8%) |
| Sept 2001 | - | -$4.71 M(-71.4%) | -$48.42 M(+11.3%) |
| June 2001 | - | -$16.46 M(-4.5%) | -$43.50 M(+23.5%) |
| Mar 2001 | - | -$17.23 M(+72.1%) | -$35.22 M(+21.5%) |
| Dec 2000 | -$28.99 M(-32.7%) | -$10.01 M(-4960.2%) | -$28.99 M(-7.9%) |
| Sept 2000 | - | $206.00 K(-102.5%) | -$31.48 M(-20.9%) |
| June 2000 | - | -$8.18 M(-25.7%) | -$39.78 M(-8.8%) |
| Mar 2000 | - | -$11.01 M(-11.9%) | -$43.61 M(+1.2%) |
| Dec 1999 | -$43.10 M(+32.6%) | -$12.50 M(+54.3%) | -$43.10 M(+6.9%) |
| Sept 1999 | - | -$8.10 M(-32.5%) | -$40.30 M(+29.6%) |
| June 1999 | - | -$12.00 M(+14.3%) | -$31.10 M(-3.1%) |
| Mar 1999 | - | -$10.50 M(+8.2%) | -$32.10 M(-1.5%) |
| Dec 1998 | -$32.50 M(+3.8%) | -$9.70 M(-981.8%) | -$32.60 M(-1.8%) |
| Sept 1998 | - | $1.10 M(-108.5%) | -$33.20 M(-10.0%) |
| June 1998 | - | -$13.00 M(+18.2%) | -$36.90 M(+9.8%) |
| Mar 1998 | - | -$11.00 M(+6.8%) | -$33.60 M(+6.7%) |
| Dec 1997 | -$31.30 M(+7.6%) | -$10.30 M(+296.2%) | -$31.50 M(+2.6%) |
| Sept 1997 | - | -$2.60 M(-73.2%) | -$30.70 M(-11.8%) |
| June 1997 | - | -$9.70 M(+9.0%) | -$34.80 M(+4.8%) |
| Mar 1997 | - | -$8.90 M(-6.3%) | -$33.20 M(+14.1%) |
| Dec 1996 | -$29.10 M(+13.7%) | -$9.50 M(+41.8%) | -$29.10 M(+12.8%) |
| Sept 1996 | - | -$6.70 M(-17.3%) | -$25.80 M(-2.6%) |
| June 1996 | - | -$8.10 M(+68.8%) | -$26.50 M(+8.6%) |
| Mar 1996 | - | -$4.80 M(-22.6%) | -$24.40 M(-5.1%) |
| Dec 1995 | -$25.60 M(+13.8%) | -$6.20 M(-16.2%) | -$25.70 M(-16.3%) |
| Sept 1995 | - | -$7.40 M(+23.3%) | -$30.70 M(+8.5%) |
| June 1995 | - | -$6.00 M(-1.6%) | -$28.30 M(+4.4%) |
| Mar 1995 | - | -$6.10 M(-45.5%) | -$27.10 M(+6.3%) |
| Dec 1994 | -$22.50 M(+23.0%) | -$11.20 M(+124.0%) | -$25.50 M(+36.4%) |
| Sept 1994 | - | -$5.00 M(+4.2%) | -$18.70 M(+3.3%) |
| June 1994 | - | -$4.80 M(+6.7%) | -$18.10 M(+1.1%) |
| Mar 1994 | - | -$4.50 M(+2.3%) | -$17.90 M(-3.2%) |
| Dec 1993 | -$18.30 M(-15.3%) | -$4.40 M(0.0%) | -$18.50 M(-14.0%) |
| Sept 1993 | - | -$4.40 M(-4.3%) | -$21.50 M(-2.3%) |
| June 1993 | - | -$4.60 M(-9.8%) | -$22.00 M(+1.9%) |
| Mar 1993 | - | -$5.10 M(-31.1%) | -$21.60 M(+0.5%) |
| Dec 1992 | -$21.60 M(+105.7%) | -$7.40 M(+51.0%) | -$21.50 M(+12.6%) |
| Sept 1992 | - | -$4.90 M(+16.7%) | -$19.10 M(+15.1%) |
| June 1992 | - | -$4.20 M(-16.0%) | -$16.60 M(+12.9%) |
| Mar 1992 | - | -$5.00 M(0.0%) | -$14.70 M(+33.6%) |
| Dec 1991 | -$10.50 M(+133.3%) | -$5.00 M(+108.3%) | -$11.00 M(-8.3%) |
| Sept 1991 | - | -$2.40 M(+4.3%) | -$12.00 M(+31.9%) |
| June 1991 | - | -$2.30 M(+76.9%) | -$9.10 M(+44.4%) |
| Mar 1991 | - | -$1.30 M(-78.3%) | -$6.30 M(+40.0%) |
| Dec 1990 | -$4.50 M | -$6.00 M(-1300.0%) | -$4.50 M(-400.0%) |
| Sept 1990 | - | $500.00 K(0.0%) | $1.50 M(+50.0%) |
| June 1990 | - | $500.00 K(0.0%) | $1.00 M(+100.0%) |
| Mar 1990 | - | $500.00 K | $500.00 K |
FAQ
- What is Ionis Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual operating profit year-on-year change?
- What is Ionis Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly operating profit year-on-year change?
- What is Ionis Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM operating profit year-on-year change?
What is Ionis Pharmaceuticals annual operaing income?
The current annual operating profit of IONS is -$353.71 M
What is the all time high annual operating profit for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual operaing income is $365.88 M
What is Ionis Pharmaceuticals annual operating profit year-on-year change?
Over the past year, IONS annual operaing income has changed by +$56.48 M (+13.77%)
What is Ionis Pharmaceuticals quarterly operating income?
The current quarterly operating profit of IONS is -$148.62 M
What is the all time high quarterly operating profit for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly operating income is $260.65 M
What is Ionis Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, IONS quarterly operating income has changed by -$5.30 M (-3.70%)
What is Ionis Pharmaceuticals TTM operating income?
The current TTM operating profit of IONS is -$370.33 M
What is the all time high TTM operating profit for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM operating income is $365.88 M
What is Ionis Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, IONS TTM operating income has changed by +$185.29 M (+33.35%)